Rivaroxaban Linked to Low VTE Recurrence in Active Cancer

MONDAY, May 21, 2018 -- For patients with active cancer and venous thromboembolism (VTE), rivaroxaban is associated with lower VTE recurrence compared with dalteparin, but with elevated clinically relevant non-major bleeding (CRNMB), according to a...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news